Australia's most trusted
source of pharma news
Tuesday, 25 November 2025
Tuesday, 25 November 2025
Subscribe
Login
News Headlines
News Headlines
News
Combo proves 'practice-changing'
Posted 25 November 2025 AM
A "practice-changing" combo is the first to get FDA approval for certain types of bladder cancer, with the approval coming months earlier than the pharmas involved anticipated.
The FDA has approved MSD's PD-1 inhibitor Keytruda and Keytruda Qlex, each in combination with Astellas' antibody-drug conjugate Padcev, as neoadjuvant treatment and then continued after surgery as adjuvant treatment for adult patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-containing chemotherapy.
To see the whole article, please login
Posted 25 November 2025 AM
A "practice-changing" combo is the first to get FDA approval for certain types of bladder cancer, with the approval coming months earlier than the pharmas involved anticipated.
The FDA has approved MSD's PD-1 inhibitor Keytruda and Keytruda Qlex, each in combination with Astellas' antibody-drug conjugate Padcev, as neoadjuvant treatment and then continued after surgery as adjuvant treatment for adult patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-containing chemotherapy.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Sales & Customer Relations (14)
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Customer Service Representative - St Leonards
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
Clinical & Medical, R&D (6)
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
Regulatory, Pharmacovigilance & QA (5)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
- Quality assurance associate - Sydney
- Pharmacovigilance Associate - Sydney
Other (15)
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Finance Business Partner - Surry Hills
- Technical Service & Warehouse Coordinator - Alexandria
- Compliance & Legal Director - Macquarie Park
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.